Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome
Authors:
- Tadashi YamaguchiTYTadashi Yamaguchi
- Shoji TsujiSTShoji Tsuji
- Shohei AkagawaSAShohei Akagawa
- Yuko AkagawaYAYuko Akagawa
- Jiro KinoJKJiro Kino
- Sohsaku YamanouchiSYSohsaku Yamanouchi
- Takahisa KimataTKTakahisa Kimata
- Masaki HashiyadaMHMasaki Hashiyada
- Atsushi AkaneAAAtsushi Akane
- Kazunari KanekoKKKazunari Kaneko
Open Access
Abstract
We previously reported that a decrease in butyrate-producing bacteria in the gut is a potential cause of regulatory T cell (Treg) abnormalities in children with idiopathic nephrotic syndrome (INS). Therefore, we hypothesized that administration of butyrate-producing bacteria might reduce INS relapse and the need for immunosuppressants in these patients. Twenty patients in remission from INS (median age 5.3 years, 15 boys) were enrolled in the study and assigned to receive either daily oral treatment with a preparation of 3 g Clostridium butyricum or no probiotic treatment. The number of relapses and requirement for immunosuppressive agents were compared between the two groups. In the probiotic treatment group, analyses of the gut microbiota and Treg measurements were also performed. Probiotic-treated patients experienced fewer INS relapses per year compared with non-probiotic-treated patients (p = 0.016). Further, administration of rituximab in the probiotic treatment group was significantly less frequent compared with the non-probiotic-treated group (p = 0.025). In the probiotic treatment group, analyses before and after probiotic treatment revealed the significant increases in the relative abundance of butyrate-producing bacteria (p = 0.017) and blood Treg counts (p = 0.0065). Thus, oral administration of butyrate-producing bacteria during INS remission may reduce the frequency of relapse and the need for immunosuppressive agents.Keywords
This publication has 38 references indexed in Scilit:
- Clostridium butyricum reduce lipogenesis through bacterial wall components and butyrateApplied Microbiology and Biotechnology, 2014
- Antibiotic exposure in the first two years of life and development of asthma and other allergic diseases by 7.5 yr: A dose‐dependent relationshipPediatric Allergy and Immunology, 2013
- Chronic kidney disease alters intestinal microbial floraKidney International, 2013
- Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGOPediatric Nephrology, 2012
- Chapter 3: Steroid-sensitive nephrotic syndrome in childrenKidney International Supplements, 2012
- Induction of Colonic Regulatory T Cells by Indigenous Clostridium SpeciesScience, 2011
- T regulatory cell function in idiopathic minimal lesion nephrotic syndromePediatric Nephrology, 2009
- The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndromePediatric Nephrology, 2009
- Nephrotic syndrome in childhoodThe Lancet, 2003
- PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTIONThe Lancet, 1974